1 2 3
Laboratory Report.
Name : DEEKSHIT Sr. Number :1
Age : 19 Gender : MALE Invoice Date : 13-05-2025
Ref. By Dr : SELF Invoice Number : 123
Registration No.: 762
Collected On : 13-05-2025
Received On : 13-05-2025
Complete Blood Cell Count
Test Name Observed Values Reference Intervals Units
HAEMOGLOBIN 12.4 12--18 gm/dl.
TOTAL W.B.C. COUNT 9400 4000--11000 /cummm
D.L.C.(Differential Leucocyte Count)
NEUTROPHILS 70.00 45--70 %
LYMPHOCYTES 24.00 20--45 %
EOSINOPHILS 5.00 0--6 %
MONOCYTES 1.00 0--4 %
BASOPHILS 0.00 0--1 %
RBC (TRBC) 5.22 3.5--5.5 milli/cumm
PCV [Haematocrit] 42.3 35--45 %
MCV(MEAN CORPUSCULAR VOL) 80.1 76--96 fl.
MCH (Mean Corpuscular Hb) L 23.3 27--31 pg
MCHC (Mean [Link] Conc.) L 29.1 32--36 %
RDW 14.3 1--15 %
PLATELET COUNT 3.40 1.5--4.5 Lacs/cumm
MPV 7.9 6.5--11.5 %
PCT 0.267 0.13--0.28 %
PDW H 15.9 1--15 %
TECHNOLOGIST PATHOLOGIST
T&C : * This Reports is Not Valid For Medico Legal Purposes. * Identification and name of person is not our resposnibility.
* No part of this report should be reproduced for any purpose. * Interpret result after considering Age,sex effect of drug and other
relevant factor. Page 1/5
1 2 3
Laboratory Report.
Name : DEEKSHIT Sr. Number :1
Age : 19 Gender : MALE Invoice Date : 13-05-2025
Ref. By Dr : SELF Invoice Number : 123
Registration No.: 762
Collected On : 13-05-2025
Received On : 13-05-2025
BIO-CHEMISTRY
RENAL FUNCTION TEST
Test Name Observed Values Reference Intervals Units
Blood Urea 21.90 13--45 mg/dL
Creatinine 0.84 0.4--1.4 mg/dL
BUN (Blood Urea Nitrogen) 10.22 7--30 mg/dL
Interpretation
Creatinine:
Because serum creatinine is inversely correlated with glomerular filtration rate (GFR), when renal function is near normal,
absolute changes in serum creatinine reflect larger changes than do similar absolute changes when renal function is poor.
For example, an increase in serum creatinine from 1 to 2 mg/dL may indicate a decrease in GFR of 50 mL/min (from 100
to 50 mL/min), whereas an increase in serum creatinine level from 4 to 5 mg/dL may indicate a decrease of only 5 mL/min
(from 25 to 20 mL/min).
Serum blood urea nitrogen (BUN) determinations are considerably less sensitive than BUN clearance (and creatinine
clearance) tests, and levels may not be abnormal until the BUN clearance has diminished to <50%. Clinicians frequently
calculate a convenient relationship, the urea nitrogen/creatinine ratio: serum bun in mg/dL/serum creatinine in mg/dL. For
a normal individual on a normal diet, the reference interval for the ratio ranges between 12 and 20, with most individuals
being between 12 and 16. Significantly lower ratios denote acute tubular necrosis, low protein intake, starvation or severe
liver disease. High ratios with normal creatinine levels may be noted with catabolic states of tissue breakdown, prerenal
azotemia, high protein intake, etc. High ratios associated with high creatinine concentrations may denote either postrenal
obstruction or prerenal azotemia superimposed on renal disease. Because of the variability of both the BUN and creatinine
assays, the ratio is only a rough guide to the nature of the underlying abnormality. Its magnitude is not tightly regulated in
health or disease and should not be considered an exact quantity.
TECHNOLOGIST PATHOLOGIST
T&C : * This Reports is Not Valid For Medico Legal Purposes. * Identification and name of person is not our resposnibility.
* No part of this report should be reproduced for any purpose. * Interpret result after considering Age,sex effect of drug and other
relevant factor. Page 2/5
1 2 3
Laboratory Report.
Name : DEEKSHIT Sr. Number :1
Age : 19 Gender : MALE Invoice Date : 13-05-2025
Ref. By Dr : SELF Invoice Number : 123
Registration No.: 762
Collected On : 13-05-2025
Received On : 13-05-2025
BIO-CHEMISTRY
Liver Function Test
Test Name Observed Values Reference Intervals Units
S.G.O.T. 15.80 0--35 U/L
S.G.P.T. 19.90 0--49 U/L
Bilirubin(Total) 0.76 0.1--1.4 mg/dL
Bilirubin(Direct) 0.17 0--0.3 mg/dL
Bilirubin(Indirect) 0.59 0.1--0.9 mg/dL
Total Protein 7.32 6--8 mg/dL
Albumin 4.70 3.5--5 mg/dL
Globulin L 2.62 3--4.5 mg/dL
A/G Ratio H 1.79 0.5 -- 1.2 g/dL
Alkaline Phosphatase 178.00 108--306 U/L
Interpretation :
SGOT: Elevated aspartate aminotransferase (AST) values are seen in parenchymal liver diseases characterized by a destruction of hepatocytes.
Values are typically at least 10 times above the normal range. Levels may reach values as high as one hundred times the upper reference limit,
although twenty to fifty-fold elevations are most frequently encountered. In infectious hepatitis and other inflammatory conditions affecting the liver,
alanine aminotransferase (ALT) is characteristically as high as or higher than AST, and the ALT/AST ratio, which normally and in other condition is
<1, becomes greater than unity. AST levels are usually elevated before clinical signs and symptoms of disease appear. Five- to 10-fold elevations of
both AST and ALT occur in patients with primary or metastatic carcinoma of the liver, with AST usually being higher than ALT, but levels are often
normal in the early stages of malignant infiltration of the liver. Elevations of ALT activity persist longer than do those of AST activity. Elevated AST
values may also be seen in disorders affecting the heart, skeletal muscle and kidney.
SGPT: Elevated alanine aminotransferase (ALT) values are seen in parenchymal liver diseases characterized by a destruction of hepatocytes.
Values are typically at least ten times above the normal range. Levels may reach values as high as one hundred times the upper reference limit,
although twenty to fifty-fold elevations are most frequently encountered. In infectious hepatitis and other inflammatory conditions affecting the liver,
ALT is characteristically as high as or higher than aspartate aminotransferase (AST), and the ALT/AST ratio, which normally and in other condition is
<1, becomes greater than unity. ALT levels are usually elevated before clinical signs and symptoms of disease appear.
Bilirubin: The level of bilirubinemia that results in kernicterus in a given infant is unknown, While central nervous system damage is rare when total
serum bilirubin (TSB) is <20 mg/dL, premature infants may be affected at lower levels. The decision to institute therapy is based on a number of
factors including TSB, age, clinical history, physical examination and coexisting conditions. Phototherapy typically is discontinued when TSB level
reaches 14 to 15 mg/dL.
Physiologic jaundice should resolve in 5 to 10 days in full-term infants and by 14 days in preterm infants.
In preterm infants, the risk of a handicap increases by 30% for each 2.9 mg/dL increase of maximal total bilirubin concentration.
When any portion of the biliary tree becomes blocked, bilirubin levels will increase.
TECHNOLOGIST PATHOLOGIST
T&C : * This Reports is Not Valid For Medico Legal Purposes. * Identification and name of person is not our resposnibility.
* No part of this report should be reproduced for any purpose. * Interpret result after considering Age,sex effect of drug and other
relevant factor. Page 3/5
1 2 3
Laboratory Report.
Name : DEEKSHIT Sr. Number :1
Age : 19 Gender : MALE Invoice Date : 13-05-2025
Ref. By Dr : SELF Invoice Number : 123
Registration No.: 762
Collected On : 13-05-2025
Received On : 13-05-2025
BIO-CHEMISTRY
LIPID PROFILE
Test Name Observed Values Reference Intervals Units
Cholesterol 137.00 110--200 mg/dL
HDL Cholesterol 49.00 35--88 mg/dL
Triglycerides 114.00 40--165 mg/dL
LDL Cholesterol 65.20 0--100 mg/dL
VLDL Cholesterol 22.80 0--35 mg/dL
LIPID PROFILE COMMENTS:
All above biological reference interval/sranges are in accordance to the recommendatons of The Natonal Cholesterol
Educaton Program(N CEP) Adult Treatment Panel III. (ATP III) Guidelines providing the most desirable targets of various
circulatng lipid fractons in the blood Lipid level assessments must be made following 9 to 12 hours of fasting otherwise
assay results might lead to erroneous interpretation NCEP recommends the assessment of3 diferent samples drawn at
intervals of week for harmonizing biological variables that might be encountered in single assays. Therapeutc target levels
of lipids as per NCEP ATP III recommendaton:
Total Cholesterol (mg/dL) <200 - Desirable 200-239 -Borderline high <240 - High
HDL Cholesterol(mg/dL), <40 - Low >60 - High
LDL Cholesterol(mg/dL) <100 Optmal
[ Primary Target of Therapy] 100-129 Near optmal/above optmal
130-159 Borderline high
160-189 High
>190 Very high
Serum Triglycerides (mg/dL) <150 Normal
150-199 Borderline high
200-499 High
>500 Very high
NCEP recommends lowering of LDL Cholesterol as the primary therapeutc target with lipid lowering age, nhtoswever, if
triglycerides remain> 200 mg/dL afer LDL goal is reached, set secondary goal for non-HDL cholesterol (tota l minus HDL)
30 mg/dL higher than LDL goal.
Comparison of LDL Cholesterol and Non-HDL Cholesterol Goals for Three Risk Categories
Risk Category LDL Goal (mg/dL) Non-HDL Goal (mg/dL)
CHD and CHD Risk Equivalent <100 <130
(10-year risk for CHD >20%)
Multple (2+) Risk Factors and <130 <160
10-year risk <20%
TECHNOLOGIST PATHOLOGIST
T&C : * This Reports is Not Valid For Medico Legal Purposes. * Identification and name of person is not our resposnibility.
* No part of this report should be reproduced for any purpose. * Interpret result after considering Age,sex effect of drug and other
relevant factor. Page 4/5
1 2 3
Laboratory Report.
Name : DEEKSHIT Sr. Number :1
Age : 19 Gender : MALE Invoice Date : 13-05-2025
Ref. By Dr : SELF Invoice Number : 123
Registration No.: 762
Collected On : 13-05-2025
Received On : 13-05-2025
0-1 Risk Factor <160 <190
Low HDL levels are an independent risk factor for occurrence of coronary artery disease. When Triglyceride level is > 400
mg/dL, Friedewald Equaton is not applicable for calculaton of LD&L VLDL. Hence the calculated values are not provided
for such samples.
<<< END OF REPORT >>>
TECHNOLOGIST PATHOLOGIST
T&C : * This Reports is Not Valid For Medico Legal Purposes. * Identification and name of person is not our resposnibility.
* No part of this report should be reproduced for any purpose. * Interpret result after considering Age,sex effect of drug and other
relevant factor. Page 5/5
Powered by TCPDF ([Link])